FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043023257> ?p ?o ?g. }

• W2043023257 endingPage "3579" @default.
• W2043023257 startingPage "3571" @default.
• W2043023257 abstract "Abstract Purpose: Treatment with abiraterone (abi) acetate prolongs survival in castration-resistant prostate cancer (CRPC). Resistance to abi invariably occurs, probably due in part to upregulation of steroidogenic enzymes and/or other mechanisms that sustain dihydrotestosterone (DHT) synthesis, which raises the possibility of reversing resistance by concomitant inhibition of other required steroidogenic enzymes. On the basis of the 3β-hydroxyl, Δ5-structure, we hypothesized that abi also inhibits 3β-hydroxysteroid dehydrogenase/isomerase (3βHSD), which is absolutely required for DHT synthesis in CRPC, regardless of origins or routes of synthesis. Experimental Design: We tested the effects of abi on 3βHSD activity, androgen receptor localization, expression of androgen receptor–responsive genes, and CRPC growth in vivo. Results: Abi inhibits recombinant 3βHSD activity in vitro and endogenous 3βHSD activity in LNCaP and LAPC4 cells, including conversion of [3H]-dehydroepiandrosterone (DHEA) to Δ4-androstenedione, androgen receptor nuclear translocation, expression of androgen receptor–responsive genes, and xenograft growth in orchiectomized mice supplemented with DHEA. Abi also blocks conversion of Δ5-androstenediol to testosterone by 3βHSD. Abi inhibits 3βHSD1 and 3βHSD2 enzymatic activity in vitro; blocks conversion from DHEA to androstenedione and DHT with an IC50 value of less than 1 μmol/L in CRPC cell lines; inhibits androgen receptor nuclear translocation; expression of TMPRSS2, prostate-specific antigen, and FKBP5; and decreases CRPC xenograft growth in DHEA-supplemented mice. Conclusions: We conclude that abi inhibits 3βHSD-mediated conversion of DHEA to active androgens in CRPC. This second mode of action might be exploited to reverse resistance to CYP17A1 inhibition at the standard abi dose by dose-escalation or simply by administration with food to increase drug exposure. Clin Cancer Res; 18(13); 3571–9. ©2012 AACR." @default.
• W2043023257 created "2016-06-24" @default.
• W2043023257 creator A5020994370 @default.
• W2043023257 creator A5037987036 @default.
• W2043023257 creator A5049645907 @default.
• W2043023257 creator A5052247491 @default.
• W2043023257 creator A5055037280 @default.
• W2043023257 creator A5065001025 @default.
• W2043023257 creator A5081675173 @default.
• W2043023257 creator A5087395756 @default.
• W2043023257 date "2012-07-01" @default.
• W2043023257 modified "2023-10-12" @default.
• W2043023257 title "Abiraterone Inhibits 3β-Hydroxysteroid Dehydrogenase: A Rationale for Increasing Drug Exposure in Castration-Resistant Prostate Cancer" @default.
• W2043023257 cites W1601645816 @default.
• W2043023257 cites W2009171847 @default.
• W2043023257 cites W2027081726 @default.
• W2043023257 cites W2041880296 @default.
• W2043023257 cites W2059809971 @default.
• W2043023257 cites W2064360128 @default.
• W2043023257 cites W2071489707 @default.
• W2043023257 cites W2078222208 @default.
• W2043023257 cites W2081365151 @default.
• W2043023257 cites W2083073798 @default.
• W2043023257 cites W2107991694 @default.
• W2043023257 cites W2110534364 @default.
• W2043023257 cites W2113747492 @default.
• W2043023257 cites W2133328863 @default.
• W2043023257 cites W2141569270 @default.
• W2043023257 cites W2144492823 @default.
• W2043023257 cites W2147166694 @default.
• W2043023257 cites W2150609534 @default.
• W2043023257 cites W2151317340 @default.
• W2043023257 cites W2157980218 @default.
• W2043023257 cites W2161282696 @default.
• W2043023257 cites W2167634604 @default.
• W2043023257 cites W2170544517 @default.
• W2043023257 cites W2171914103 @default.
• W2043023257 cites W2950142636 @default.
• W2043023257 doi "https://doi.org/10.1158/1078-0432.ccr-12-0908" @default.
• W2043023257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22753664" @default.
• W2043023257 hasPublicationYear "2012" @default.
• W2043023257 type Work @default.
• W2043023257 sameAs 2043023257 @default.
• W2043023257 citedByCount "89" @default.
• W2043023257 countsByYear W20430232572012 @default.
• W2043023257 countsByYear W20430232572013 @default.
• W2043023257 countsByYear W20430232572014 @default.
• W2043023257 countsByYear W20430232572015 @default.
• W2043023257 countsByYear W20430232572016 @default.
• W2043023257 countsByYear W20430232572017 @default.
• W2043023257 countsByYear W20430232572018 @default.
• W2043023257 countsByYear W20430232572019 @default.
• W2043023257 countsByYear W20430232572020 @default.
• W2043023257 countsByYear W20430232572021 @default.
• W2043023257 countsByYear W20430232572022 @default.
• W2043023257 countsByYear W20430232572023 @default.
• W2043023257 crossrefType "journal-article" @default.
• W2043023257 hasAuthorship W2043023257A5020994370 @default.
• W2043023257 hasAuthorship W2043023257A5037987036 @default.
• W2043023257 hasAuthorship W2043023257A5049645907 @default.
• W2043023257 hasAuthorship W2043023257A5052247491 @default.
• W2043023257 hasAuthorship W2043023257A5055037280 @default.
• W2043023257 hasAuthorship W2043023257A5065001025 @default.
• W2043023257 hasAuthorship W2043023257A5081675173 @default.
• W2043023257 hasAuthorship W2043023257A5087395756 @default.
• W2043023257 hasBestOaLocation W20430232572 @default.
• W2043023257 hasConcept C104317684 @default.
• W2043023257 hasConcept C121608353 @default.
• W2043023257 hasConcept C126322002 @default.
• W2043023257 hasConcept C127561419 @default.
• W2043023257 hasConcept C134018914 @default.
• W2043023257 hasConcept C185592680 @default.
• W2043023257 hasConcept C2775832370 @default.
• W2043023257 hasConcept C2776992908 @default.
• W2043023257 hasConcept C2777899217 @default.
• W2043023257 hasConcept C2777911890 @default.
• W2043023257 hasConcept C2779279991 @default.
• W2043023257 hasConcept C2779723316 @default.
• W2043023257 hasConcept C2779881493 @default.
• W2043023257 hasConcept C2780192828 @default.
• W2043023257 hasConcept C502942594 @default.
• W2043023257 hasConcept C55493867 @default.
• W2043023257 hasConcept C61367390 @default.
• W2043023257 hasConcept C71315377 @default.
• W2043023257 hasConcept C71924100 @default.
• W2043023257 hasConcept C86803240 @default.
• W2043023257 hasConceptScore W2043023257C104317684 @default.
• W2043023257 hasConceptScore W2043023257C121608353 @default.
• W2043023257 hasConceptScore W2043023257C126322002 @default.
• W2043023257 hasConceptScore W2043023257C127561419 @default.
• W2043023257 hasConceptScore W2043023257C134018914 @default.
• W2043023257 hasConceptScore W2043023257C185592680 @default.
• W2043023257 hasConceptScore W2043023257C2775832370 @default.
• W2043023257 hasConceptScore W2043023257C2776992908 @default.
• W2043023257 hasConceptScore W2043023257C2777899217 @default.
• W2043023257 hasConceptScore W2043023257C2777911890 @default.
• W2043023257 hasConceptScore W2043023257C2779279991 @default.
• W2043023257 hasConceptScore W2043023257C2779723316 @default.

• next